Aethlon Medical, Inc.
AEMD
$0.58
-$0.02-2.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 69.87% | -15.01% | 47.02% | 31.48% | -157.89% |
| Total Depreciation and Amortization | -10.96% | 0.65% | 0.13% | -4.07% | -246.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -92.85% | -19.56% | -99.83% | 4.78% | 3,087.74% |
| Change in Net Operating Assets | 68.42% | 83.20% | -257.04% | -130.08% | 32.29% |
| Cash from Operations | -4.65% | 6.78% | 25.10% | 1.87% | 34.80% |
| Capital Expenditure | -195.45% | 22.73% | -- | -- | 144.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -195.45% | 22.73% | -- | -- | 144.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | 7,311.24% |
| Repurchase of Common Stock | 65.52% | 83.10% | 13.16% | -5.88% | 59.72% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 85.28% | -- | -- | -- | -- |
| Cash from Financing | -108.33% | 42,108.45% | 98,550.00% | -100.10% | 5,437.79% |
| Foreign Exchange rate Adjustments | 900.00% | 74.26% | 23.53% | -1,092.31% | -4.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -381.22% | 154.25% | 194.37% | -147.81% | 127.12% |